Despite the evolution of endoscopic sinus surgery and a growing understanding of the pathophysiologic mechanisms of chronic rhinosinusitis (CRS), it remains a prevalent health care problem, afflicting approximately 30 million Americans.

Image-guided sinus (IGS) and skull base surgery is no longer considered experimental or investigational, and is appropriate for use by otolaryngologic surgeons to help clarify complex anatomy encountered during functional endoscopic sinus and skull base surgery (FESS).
As otolaryngologists and facial plastic surgeons, we are fortunate to have the opportunity to perform many challenging operations of the head and neck.
A new Food and Drug Administration (FDA) advisory warns that the combined use of triptans and selective serotonin reuptake inhibitors (SSRIs) or selective serotonin/norepinephrine reuptake inhibitors (SNRIs) may result in life-threatening serotonin syndrome, which occurs when the body has too much serotonin.
Researchers from Johns Hopkins School of Medicine have identified a means of detecting thyroidectomy patients who can safely be discharged early after surgery, with little risk of developing significant hypocalcemia.
What patient wouldn’t want three or four very small incisions that heal rapidly with little or no scarring and no residual numbness, compared with a foot-long slice at or under the hairline that takes longer to heal and sometimes leaves a puffed-up scar and/or permanent loss of sensation?
The internal nasal valve region is responsible for more than two-thirds of the airflow resistance produced by the nose and represents the most constricted point of the upper airway.